6 April 2020 - proposed placing

The company has conditionally raised gross proceeds of £3.75m through a placing at a price of 18p per share.  This follows news of a subscription for £2m of shares at the same price which was announced on 2 April.  An update on current trading has also been released.  Following the collaboration and option agreement with ADC Therapeutics at the end of 2019, Avacta has successfully expanded the LG Chem Life Sciences Partnership and established a joint venture with Daewoong Pharmaceutical Co. Ltd in South Korea.  Revenues for the 17 month period to 31 December . . .

This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.

Already a member, log in HERE.